Unresectable Pancreatic Adenocarcinoma
12 clinical trials · Condition
◉ Watch Unresectable Pancreatic Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer (NCT04514497) | National Cancer Institute (NCI) | 2021-10-20 |
| Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors (NCT04616534) | National Cancer Institute (NCI) | 2021-06-01 |
| Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial (NCT03878524) | OHSU Knight Cancer Institute | 2020-04-01 |
| Ambulatory Measurement of Physical Activity in Pancreatic Cancer Patients (NCT03490604) | Centre Hospitalier Universitaire Dijon | 2018-07-02 |
| A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors (NCT02498613) | National Cancer Institute (NCI) | 2016-08-31 |
Track Unresectable Pancreatic Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.